Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta‐Analysis
Wirksamkeit und Sicherheit verschiedener Hybrid-Closed-Loop-Systeme zur automatisierten Insulinabgabe bei Menschen mit Typ-1-Diabetes: systematische Übersicht und Netzwerk-Metaanalyse
Diabetes/Metabolism Research and Reviews · 2024-09 · 40 (6)
DOI: 10.1002/dmrr.3842 ↗Auf einen Blick
28 RCTs zeigen: HCL-Systeme erhöhten die Zeit im Zielbereich gegenüber subkutaner Insulintherapie ohne kontinuierliche Glukosemessung. Minimed 780G erreichte die höchste TIR.
Fragestellung
Wie wirksam und sicher sind verschiedene Hybrid-Closed-Loop-Systeme bei Menschen mit Diabetes im Vergleich zu anderen Insulintherapien?
Methode
Systematische Übersicht und Netzwerk-Metaanalyse randomisierter klinischer Studien; Suche in MEDLINE, EMBASE, CENTRAL und PubMed.
Ergebnisse
28 RCTs, alle mit Menschen mit Typ-1-Diabetes. Minimed 780G lag bei TIR vor Control-IQ (MD 5,1 %, 95 %-KI 0,68–9,52), Minimed 670G (MD 7,48 %, 95 %-KI 4,27–10,7), CamAPS Fx (MD 8,94 %, 95 %-KI 4,35–13,54) und DBLG1 (MD 10,69 %, 95 %-KI 5,73–15,65).
Schlussfolgerung der Autor:innen
Die Autor:innen berichten eine Wirksamkeitshierarchie zwischen den HCL-Systemen bei Menschen mit Typ-1-Diabetes und sehen dies als Unterstützung für klinische Entscheidungen.
Kernaussagen
- HCL-Systeme erhöhten die Time in Range gegenüber SIT ohne CGM.
- Minimed 780G erzielte die höchste TIR.
- Schwere Hypoglykämie und DKA waren ähnlich häufig wie unter anderer Insulintherapie.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift Diabetes/Metabolism Research and Reviews, online erschienen am 19.09.2024. Verfasst von Sergio Di Molfetta und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, Uni…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Hypoglycemic Agents, Insulin, Insulin Infusion Systems. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Next Generation EU, National Recovery and Resilience Plan, Investment PE8-Project Age-It: 'Ageing Well in an Ageing Society'.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
To compare the efficacy and safety of different hybrid closed loop (HCL) systems in people with diabetes through a network meta‐analysis.
Methods
We searched MEDLINE, EMBASE, CENTRAL and PubMed for randomised clinical trials (RCTs) enrolling children, adolescents and/or adults with type 1 or type 2 diabetes, evaluating Minimed 670G, Minimed 780G, Control‐IQ, CamAPS Fx, DBLG‐1, DBLHU, and Omnipod 5 HCL systems against other types of insulin therapy, and reporting time in target range (TIR) as outcome.
Results
A total of 28 RCTs, all enrolling people with type 1 diabetes, were included. HCL systems significantly increased TIR compared with subcutaneous insulin therapy without continuous glucose monitoring (SIT). Minimed 780G achieved the highest TIR ahead of Control IQ (mean difference (MD) 5.1%, 95% confidence interval (95% CI) [0.68; 9.52], low certainty), Minimed 670G (MD 7.48%, 95% CI [4.27; 10.7], moderate certainty), CamAPS Fx (MD 8.94%, 95% CI [4.35; 13.54], low certainty), and DBLG1 (MD 10.69%, 95% CI [5.73; 15.65], low certainty). All HCL systems decreased time below target range, with DBLG1 (MD −3.69%, 95% CI [−5.2; −2.19], high certainty), Minimed 670G (MD −2.9%, 95% CI [−3.77; −2.04], moderate certainty) and Minimed 780G (MD −2.79%, 95% CI [−3.94; −1.64], high certainty) exhibiting the largest reductions compared to SIT. The risk of severe hypoglycaemia and diabetic ketoacidosis was similar to other types of insulin therapy.
Conclusions
We show a hierarchy of efficacy among the different HCL systems in people with type 1 diabetes, thus providing support to clinical decision‐making. Trial Registration: PROSPERO CRD42023453717
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy.
- Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.
- Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, Bari, Italy.
- Sydney School of Public Health, The University of Sydney, Sydney, Australia.
- Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
ORCID-Profile: Sergio Di Molfetta, Ludovico Di Gioia, Irene Caruso, Angelo Cignarelli, Suetonia C Green, Patrizia Natale, Giovanni F M Strippoli, Gian Pio Sorice, Sebastio Perrini, Annalisa Natalicchio, Luigi Laviola, Francesco Giorgino
Förderung
- Next Generation EU, National Recovery and Resilience Plan, Investment PE8-Project Age-It: 'Ageing Well in an Ageing Society'
Zitieren
APA
Di Molfetta, S., Di Gioia, L., Caruso, I., Cignarelli, A., Green, S. C., Natale, P., Strippoli, G. F. M., Sorice, G. P., Perrini, S., Natalicchio, A., Laviola, L., & Giorgino, F. (2024). Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta‐Analysis. Diabetes/Metabolism Research and Reviews, 40(6). https://doi.org/10.1002/dmrr.3842
Vancouver
Di Molfetta S, Di Gioia L, Caruso I, Cignarelli A, Green SC, Natale P, et al. Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta‐Analysis. Diabetes/Metabolism Research and Reviews. 2024;40(6). doi:10.1002/dmrr.3842
BibTeX
@article{DiMolfetta2024,
author = {Di Molfetta, Sergio and Di Gioia, Ludovico and Caruso, Irene and Cignarelli, Angelo and Green, Suetonia C and Natale, Patrizia and Strippoli, Giovanni F M and Sorice, Gian Pio and Perrini, Sebastio and Natalicchio, Annalisa and Laviola, Luigi and Giorgino, Francesco},
title = {Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta‐Analysis},
journal = {Diabetes/Metabolism Research and Reviews},
year = {2024},
volume = {40},
number = {6},
doi = {10.1002/dmrr.3842}
}
EUVIMED